NXT Capital's Venture Finance Group today announced the closing of a $8.0 million venture loan package to Cayenne Medical, Inc. Made in cooperation with Silicon Valley Bank, the facility will be used to strengthen Cayenne's balance sheet and further the successful growth of existing products, as well as bolster marketing efforts around the recent commercialization of a new suite of medical devices.

Cayenne Medical markets products that address previously unmet clinical needs in knee ligament reconstruction and meniscal repair, including the AperFix II System, the CrossFix II System and the iFix System. Most recently, the company launched the Quattro Shoulder System for rotator cuff and labral repairs. Headquartered in Scottsdale, Arizona, Cayenne Medical is backed by Split Rock Partners, Investor Growth Capital, Fletcher Spaght Ventures and Memphis Biomed Ventures.

"To complement our recent equity financing, we were looking for a debt facility that would provide additional capacity to invest in sales and marketing initiatives and fund working capital to support our business expansion. NXT Capital Venture Finance and Silicon Valley Bank provided the flexibility we needed," said Randy Buness, Cayenne Medical's CFO. "NXT and Silicon Valley Bank's collective ability to listen and build a structure that addresses a company's unique needs makes them excellent financing partners."

"Cayenne has a well-established reputation for high-quality soft-tissue devices for surgical repair of the knee. Their new and innovative shoulder repair products will only strengthen their presence as a growing leader in sports medicine orthopedics," said Peter Fair, Managing Director, NXT Capital Venture Finance. "We are excited to partner with such an impressive company and management team."

"We aspire to help our life science clients like Cayenne continue to make medical advancements by growing their businesses," said Dax Williamson, Deal Team Leader, Southwest Region, Silicon Valley Bank. "Flexible and thoughtful financing at this stage of Cayenne's growth is designed to help the company continue to meet its ambitious goals. We look forward to our continued partnership."

ABOUT NXT CAPITAL VENTURE FINANCE:

NXT Capital Venture Finance is committed to serving entrepreneurs by providing less dilutive, more flexible forms of capital. With offices in Boston and Silicon Valley, NXT Capital Venture Finance provides senior and subordinated term loans in the $1 million to $20 million range to emerging growth companies backed by venture capital and private equity firms, particularly those in the technology and life science sectors. Target clients range from pre-revenue companies led by dedicated entrepreneurs to late-stage, proven businesses seeking more efficient growth capital. For more information, see www.nxtcapital.com/venture-finance.

ABOUT NXT CAPITAL:

NXT Capital provides structured financing solutions to middle-market and emerging growth companies, as well as real estate investors, through its Corporate Finance, Venture Finance and Real Estate Finance groups. Based in Chicago with offices in New York, Atlanta, Boston, Dallas, Newport Beach and Silicon Valley, NXT Capital targets senior financing opportunities up to $150 million with a hold size up to $50 million. See www.nxtcapital.com.

ABOUT SILICON VALLEY BANK:

Silicon Valley Bank is the premier bank for technology, life science, cleantech, venture capital, private equity and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment and international banking services to its clients worldwide through 27 U.S. offices and seven international operations. (Nasdaq: SIVB) www.svb.com.

Silicon Valley Bank is the California bank subsidiary and the commercial banking operation of SVB Financial Group. Banking services are provided by Silicon Valley Bank, a member of the FDIC and the Federal Reserve System. SVB Financial Group is also a member of the Federal Reserve System.

ABOUT CAYENNE MEDICAL, INC.:

Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. The company was founded in 2005 and is focused on leading the transformation of traditional soft tissue repair procedures, by applying advanced technology through minimally invasive techniques.